Univest
Univest
  • Markets

AVIENCE BIOMEDICALS (AVIENCE) Share Price Falls 9.01% Today; Valuation Stays In Focus

  • September 15, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
AVIENCE BIOMEDICALS Share Price
AVIENCE BIOMEDICALS (AVIENCE) share price fell to Rs 327.3 today, down 9.01% from the previous close. Market cap was Rs 198.37 crore.

AVIENCE BIOMEDICALS Share Price is trading lower today after a sharp decline of 9.01% to Rs 327.30, with the company’s market capitalisation at Rs 198.37 Cr. The move makes AVIENCE BIOMEDICALS Share Price one of the key stock news items in Healthcare this morning, especially because the stock is a Micro Cap and the change came without a company-specific catalyst being established. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. For investors tracking AVIENCE BIOMEDICALS Share Price Today, the focus now shifts to the day’s price action, valuation ratios, and sector comparison rather than any unsupported explanation for the decline. Univest data shows a clean intraday decline, and the stock remains relevant for anyone following AVIENCE BIOMEDICALS Share Price Live, AVIENCE BIOMEDICALS Share Price Update and AVIENCE BIOMEDICALS Stock News.

From a market-news standpoint, AVIENCE BIOMEDICALS Share Price is noteworthy because the fall comes while the broader discussion around the company still centres on fundamental analysis, Healthcare peer positioning and market capitalisation. Univest data points to a company that is small in size but rich in profitability ratios, which is why AVIENCE BIOMEDICALS Share Price continues to attract attention even on a weak day. The combination of a lower share price, a Micro Cap profile and a premium-to-median valuation profile gives AVIENCE BIOMEDICALS Share Price a distinctly stock-analysis angle today. For readers searching Why Is AVIENCE BIOMEDICALS Falling Today, the verified answer is to the price event itself, not an unverified catalyst.

Table of Contents

Toggle
  • AVIENCE BIOMEDICALS (AVIENCE) Share Price Today: Price Action Analysis
  • AVIENCE BIOMEDICALS (AVIENCE) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching AVIENCE BIOMEDICALS
  • About AVIENCE BIOMEDICALS
  • Track AVIENCE BIOMEDICALS Share Price on Univest
  • Frequently Asked Questions
    • Why did AVIENCE BIOMEDICALS Share Price fall today?
    • What is AVIENCE BIOMEDICALS Share Price today?
    • How much did AVIENCE BIOMEDICALS Share Price decline?
    • What is the market capitalisation of AVIENCE BIOMEDICALS?
    • What are the key valuation ratios for AVIENCE BIOMEDICALS Share Price?
    • How do profitability ratios compare for AVIENCE BIOMEDICALS Share Price?
    • What do EPS and book value mean for AVIENCE BIOMEDICALS Share Price?
    • Should investors track AVIENCE BIOMEDICALS Share Price on Univest?

AVIENCE BIOMEDICALS (AVIENCE) Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 327.3
Previous Close Rs 359.7
Today's Move -Rs 32.40 (-9.01%)
Open Rs 340.05
High Rs 340.05
Low Rs 326
Market Capitalisation Rs 198.37 crore
Market Cap Category Micro Cap

AVIENCE BIOMEDICALS Share Price opened at Rs 340.05, matched the day high at Rs 340.05 and moved down to a low of Rs 326 before last trading at Rs 327.30. That compares with the previous close of Rs 359.7, so the stock is down Rs 32.4 on the day. The decline of 9.01% places AVIENCE BIOMEDICALS Share Price firmly among the day’s stronger fallers, even though the move was confined to a narrow intraday band after the open. The current market capitalisation of Rs 198.37 Cr places AVIENCE BIOMEDICALS Share Price in the Micro Cap category, which is important context when reading today’s price action. In short, AVIENCE BIOMEDICALS Share Price Today reflects a sharp gap from the prior close, a lower intraday low, and a trade that has stayed below the opening level throughout the morning session. That sets up the next question: what do the fundamentals say about AVIENCE BIOMEDICALS Share Price?

AVIENCE BIOMEDICALS (AVIENCE) Fundamental Analysis

Metric Value
Market Capitalisation Rs 198.37 crore
P/E Ratio 22.54x
P/B Ratio 8.14x
ROE 49.9%
ROCE 34.16%
EPS Rs 15.96
Book Value Per Share Rs 44.18
Dividend Yield 0%

AVIENCE BIOMEDICALS (AVIENCE) fundamental metrics show P/E 22.54x, P/B 8.14x, ROE 49.9%, ROCE 34.16%. These figures provide context only and are not a buy or sell signal.

AVIENCE BIOMEDICALS has a market capitalisation of Rs 198.37 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 22.54x, P/B at 8.14x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 49.9% and ROCE of 34.16%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 15.96, book value per share of Rs 44.18, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 34.12x, median ROE of 13.4%, median ROCE of 14.55%. Taken together, they outline the fundamentals rather than a view on the stock.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Medical Equipment/Supplies/Accessories
Benchmark Scope same industry
Company P/E Ratio 22.54x
Benchmark Median P/E 34.12x
Benchmark Average P/E 91.5x
Benchmark P/E Range 7.83x to 1,027.7x
Company P/B Ratio 8.14x
Benchmark Median P/B 3.75x
Benchmark Average P/B 4.36x
Company ROE 49.9%
Benchmark Median ROE 13.4%
Benchmark Average ROE 16.07%
Company ROCE 34.16%
Benchmark Median ROCE 14.55%
Benchmark Average ROCE 17.26%
Company Market Capitalisation Rs 198.37 crore
Benchmark Median Market Cap Rs 188.59 crore
Benchmark Average Market Cap Rs 6,432.8 crore

AVIENCE BIOMEDICALS (AVIENCE) operates in the Healthcare sector, within the Medical Equipment/Supplies/Accessories industry.

AVIENCE BIOMEDICALS (AVIENCE) has a P/E ratio of 22.54x, which is below the benchmark median of 34.12x, a difference of -33.94%. On its own, the P/E gap is a valuation reference point, not a trading call.

AVIENCE BIOMEDICALS (AVIENCE) has a ROE of 49.9%, which is above the benchmark median of 13.4%, a difference of +272.39%. AVIENCE BIOMEDICALS (AVIENCE) has a ROCE of 34.16%, which is above the benchmark median of 14.55%, a difference of +134.78%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
LENSKART SOLUTIONS LENSKART 1,17,229.24 182.28 13.36 6.85 12.55
Poly Medicure POLYMED 16,633.42 53.88 5.33 10.94 14.05
Q-LINE BIOTECH QLINE 1,569.4 28.51 6.27 25.55 22.23
3B Blackbio Dx 3BBLACKBIO 1,394.77 26.17 4.36 20.22 25.9
LAXMI DENTAL LAXMIDENTL 1,057.39 34.12 4.29 11.95 13.29

AVIENCE BIOMEDICALS (AVIENCE) has a P/E ratio of 22.54x compared with the displayed peer median of 34.12x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 49.9% compares with a peer median of 11.95% across the companies shown in the table. ROCE stood at 34.16% versus the displayed peer median of 14.05%, providing a capital-efficiency comparison. AVIENCE BIOMEDICALS (AVIENCE) has a market capitalisation of Rs 198.37 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching AVIENCE BIOMEDICALS

  • AVIENCE BIOMEDICALS Share Price fell 9.01% today, making the move important in same-day market monitoring.
  • AVIENCE BIOMEDICALS Share Price remains a Micro Cap, so even a modest move can reshape the day’s price action.
  • AVIENCE BIOMEDICALS Share Price has strong ROE and ROCE figures relative to the industry benchmark.
  • AVIENCE BIOMEDICALS Share Price trades at a P/E below the industry median, while P/B stays above the sector centre.
  • AVIENCE BIOMEDICALS Share Price is part of Healthcare stock news and peer comparison screens on Univest.

About AVIENCE BIOMEDICALS

AVIENCE BIOMEDICALS operates in the Healthcare sector and the Medical Equipment/Supplies/Accessories industry. The business context places AVIENCE BIOMEDICALS Share Price within a segment where company results are often judged by return ratios, valuation multiples and how efficiently capital is used. Based on the latest Univest figures, the company’s market position is that of a Micro Cap with a market capitalisation near the centre of its industry peer set. That framing matters for AVIENCE BIOMEDICALS Share Price because investors often compare smaller Healthcare names on profitability, book value and relative valuation rather than on size alone.

Track AVIENCE BIOMEDICALS Share Price on Univest

Use Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

You can track AVIENCE BIOMEDICALS Share Price on Univest for live updates, key ratios, 52-week levels, market capitalisation, sector context and company news. Univest also brings together AVIENCE BIOMEDICALS Stock News, AVIENCE BIOMEDICALS Share Price Today and AVIENCE BIOMEDICALS Fundamental Analysis in one place for faster reading. If you are monitoring AVIENCE BIOMEDICALS Share Price Update or AVIENCE BIOMEDICALS Latest News, the platform helps you follow the stock with structured context.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why did AVIENCE BIOMEDICALS Share Price fall today?

Ans. AVIENCE BIOMEDICALS Share Price fell 9.01% to Rs 327.30, but no company-specific catalyst is established. The verified facts point to the price event itself, along with a lower intraday range and a Micro Cap market capitalisation.

What is AVIENCE BIOMEDICALS Share Price today?

Ans. AVIENCE BIOMEDICALS Share Price is Rs 327.30, compared with a previous close of Rs 359.7. The stock opened at Rs 340.05 and traded as low as Rs 326 during the morning session.

How much did AVIENCE BIOMEDICALS Share Price decline?

Ans. AVIENCE BIOMEDICALS Share Price declined by Rs 32.4, which works out to 9.01% on the day. That makes the move a clear price fall rather than a small routine fluctuation in the session.

What is the market capitalisation of AVIENCE BIOMEDICALS?

Ans. AVIENCE BIOMEDICALS Share Price corresponds to a market capitalisation of Rs 198.37 Cr. Univest classifies the company as a Micro Cap, which is useful context when reading the day’s decline and peer comparison.

What are the key valuation ratios for AVIENCE BIOMEDICALS Share Price?

Ans. AVIENCE BIOMEDICALS Share Price has a P/E of 22.54 and a P/B of 8.14. In the same industry set, the P/E sits below the median, while the P/B is above the industry centre.

How do profitability ratios compare for AVIENCE BIOMEDICALS Share Price?

Ans. AVIENCE BIOMEDICALS Share Price shows ROE of 49.9% and ROCE of 34.16%. Both are well above the sector median and average in the same industry benchmark, which is a notable part of the stock’s profile.

What do EPS and book value mean for AVIENCE BIOMEDICALS Share Price?

Ans. AVIENCE BIOMEDICALS Share Price has EPS of Rs 15.96 and book value of Rs 44.18. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share.

Should investors track AVIENCE BIOMEDICALS Share Price on Univest?

Ans. Yes, AVIENCE BIOMEDICALS Share Price is worth tracking on Univest because the stock combines a sharp daily decline, strong returns ratios and a valuation profile that sits differently from its Healthcare peers.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply